Ionis Pharmaceuticals, Inc. · NASDAQ:IONS
Kordasiewicz Holly B. sold 60,846 Ionis Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 12, 2026 · Filed Jun 16, 2026
On Jun 12, 2026, Kordasiewicz Holly B. (EVP, Chief Development Officer) sold 60,846 Ionis Pharmaceuticals, Inc. shares at an average US$73.40 for US$4.47M under a trading plan, leaving 22,458 shares. Filed Jun 16, 2026 (Form 4).
- Sold
- 60,846 shares
- Price
- US$73.40 average (US$73.09 to US$74.05)
- Value
- US$4.47M
- Holding after
- 22,458 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Option exercise | 7,951 | US$60.89 | 30,409 | Direct |
| Jun 12, 2026 | Common Stock | Option exercise | 21,000 | US$60.89 | 51,409 | Direct |
| Jun 12, 2026 | Common Stock | Option exercise | 12,000 | US$32.60 | 63,409 | Direct |
| Jun 12, 2026 | Common Stock | Option exercise | 19,895 | US$56.78 | 83,304 | Direct |
| Jun 12, 2026 | Common Stock | Sale | 41,004 | US$73.09 | 42,300 | Direct |
| Jun 12, 2026 | Common Stock | Sale | 19,842 | US$74.05 | 22,458 | Direct |
Source
Related
- Ionis Pharmaceuticals, Inc.
- Kordasiewicz Holly B.
- Ionis Pharmaceuticals, Inc. shareholders
- Form 4 · Kordasiewicz Holly B. · Jul 9, 2026
- Form 4 · Devers Shannon L. · Oct 19, 2026
- Form 4 · Swayze Eric · Oct 19, 2026
- Form 4 · Bennett C Frank · Sep 2, 2026
- Form 4 · O'Neil Patrick R. · Sep 2, 2026
- Form 4 · Monia Brett P · Sep 2, 2026